Bio-Techne (TECH) Depreciation & Amortization (CF) (2009 - 2026)

Bio-Techne has reported Depreciation & Amortization (CF) for 18 years, with the latest figure at $24.2 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 12.34% year-over-year to $24.2 million; the trailing twelve-month figure through Mar 2026 stood at $100.3 million (down 9.49% YoY), and the FY2025 full-year result was $109.9 million, down 1.62% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $24.2 million, down from $24.7 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $28.5 million in Q3 2023, with the low at $24.2 million in Q1 2026.
• Average Depreciation & Amortization (CF) over 5 years is $26.7 million, with a median of $27.0 million recorded in 2023.
• Year-over-year, Depreciation & Amortization (CF) rose 20.21% in 2022 and declined 13.49% in 2025.
• Tracing TECH's Depreciation & Amortization (CF) over 5 years: stood at $26.7 million in 2022, then rose by 4.12% to $27.8 million in 2023, then fell by 2.59% to $27.1 million in 2024, then slipped by 8.77% to $24.7 million in 2025, then slipped by 2.19% to $24.2 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $24.2 million (Q1 2026), $24.7 million (Q4 2025), and $24.3 million (Q3 2025), per Business Quant data.

Peer Comparison